MUC1-derived peptide vaccine (Max Delbruck)

N/A

Report date: 2025/03/20 15:25:15

Base Information

Drug NameMUC1-derived peptide vaccine (Max Delbruck)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Recombinant polypeptideVaccines > Development/production technology > Inactivated vaccine > Subunit vaccine
Mechanisms of ActionT-cell surface antigen CD4 agonists
TargetsT-cell surface antigen CD4
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMax Delbruck Centrum Fur Molekulare Medizin
China Registration ClassN/A

Develop Information

Active CompaniesMax Delbruck Centrum Fur Molekulare MedizinAscenion
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A